Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon Acquires 18,181 Shares of Company Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon acquired 18,181 shares of Inspira Technologies OXY B.H.N. stock in a transaction dated Friday, October 9th. The shares were acquired at an average price of $1.67 per share, with a total value of $30,362.27. Following the completion of the purchase, the chief executive officer owned 3,664,314 shares in the company, valued at approximately $6,119,404.38. The trade was a 0.50% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Monday, September 28th, Dagi Ben-Noon bought 168,894 shares of Inspira Technologies OXY B.H.N. stock. The stock was purchased at an average cost of $0.71 per share, for a total transaction of $119,914.74.

Inspira Technologies OXY B.H.N. Trading Up 4.1%

Shares of QTEX stock traded up $0.07 during trading hours on Friday, reaching $1.76. The company’s stock had a trading volume of 13,982,775 shares, compared to its average volume of 12,416,598. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.62 and a current ratio of 2.00. Inspira Technologies OXY B.H.N. Ltd has a fifty-two week low of $0.28 and a fifty-two week high of $3.85. The company’s 50 day moving average is $0.94.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last issued its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The business had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has authorized a stock repurchase plan on Monday, June 22nd that permits the company to buyback 2,000,000,000,000 shares. This buyback authorization permits the company to purchase up to 5.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Wall Street Zen cut Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings raised Inspira Technologies OXY B.H.N. from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.